Search
+
    SEARCHED FOR:

    MARKETSMITH INDIA

    Cannot avoid market momentum but be a little more selective: Mayuresh Joshi

    The entire ecosystem will see accelerated investments and the government push through regarding the capex needs. Also, railways as a theme, defence as a theme, and shipbuilders as a theme will continue. Execution is going to be extremely important out here, says Mayuresh Joshi. He further says the earnings story and earnings growth should continue to remain strong in select domestic-focused sectors

    How will FMCG, IT and realty sector perform going ahead? Mayuresh Joshi answers

    Our own take at Marketsmith India is that the reform processes which have continued for 10 years, there would not be any significant change in terms of capital allocation for a whole host of schemes that the Modi government has embarked upon. Infra development and infra allocations are expected to double over the next five years.

    What should investors do with defence stocks? Mayuresh Joshi answers

    ​However, I think for markets with India perspective we are very-very light right now, we still like to see over the next couple of days of what transpires on the political front and therefore the initiatives that will be taken over the next few days and specifically in the budget in terms of allocations are going to be extremely critical.

    Hold Sun Pharma and Dr Reddy's; buy Natco on dips among pharma stocks: Mayuresh Joshi

    Mayuresh Joshi shares insights on pharma and telecom sectors, focusing on key players like Sun Pharma, Dr Reddy's, Bharti Hexacom, and Exide. The discussion also includes Vodafone's FPO and the potential of Li-Ion battery makers.

    TCS Q4 show trumps D-Street expectations: 5 takeaways from the earnings

    TCS Q4 Results: The company's order book for FY24 was at an all-time high of $42.7 billion and record $13.2 billion in the March quarter, led by the mega deal with Aviva and others in the emerging markets vertical.

    Mayuresh Joshi on why TCS stock deserves to be rerated

    Market expert Joshi praises TCS's outstanding financial performance, expecting a stock re-rating. Anticipates positive sector impact and growth in BFSI, energy, manufacturing, life sciences, and healthcare industries based on TCS's stellar results.

    The Economic Times
    BACK TO TOP